Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Playtech CEO picks up shares, RS Group non-exec invests

(Sharecast News) - Playtech found itself on the list of director buys on Friday, after its chief executive officer spent almost £0.3m on shares. The company said Mor Weizer bought 44,425 shares on 25 May, in a single transaction on the London Stock Exchange.

He paid 620.07p for each share, valuing the transaction at £275,464.01.

"This purchase was made in accordance with the requirements of the company's remuneration policy, under which a proportion of the annual bonus is deferred into shares for two years," Playtech said in its disclosure.

Elsewhere, a non-executive director at RS Group spent more than £90k on shares in two separate transactions.

In the first transaction, David Sleath picked up 6,222 shares at 803.5p each, valuing the transaction at £49,993.77.

The second purchase saw Sleath buy 5,226 shares for 803.6p apiece, making that purchase worth £41,996.14.

RS Group said both transactions were made on 25 May on the London Stock Exchange.

At 1411 BST, shares in RS Group were up 0.13% at 798.9p, while those in Playtech were down 0.96% at 619p.

Reporting by Josh White for Sharecast.com.

DIRECTOR SELLS

Company: Frasers Group Name: MASH Holdings Volume: 200,000 Price: 800p Value: £1,600,000.00

Company: Frasers Group Name: Michael Ashley Volume: 100,000 Price: 900p Value: £900,000.00

Company: London Stock Exchange Group Name: York Holdings II Volume: 10,208 Price: 8,287.07p Value: £845,944.11

DIRECTOR BUYS

Company: Frasers Group Name: Michael Ashley Volume: 100,000 Price: 901p Value: £901,000.00

Company: Frasers Group Name: Michael Ashley Volume: 100,000 Price: 684p Value: £684,000.00

Company: Playtech Name: Mor Weizer Volume: 44,425 Price: 620.07p Value: £275,464.01

Company: HarbourVest Global Private Equity Name: Ed Warner Volume: 5,000 Price: 2,159p Value: £107,950.00

Company: Intermediate Capital Group Name: David Bicarregui Volume: 5,000 Price: 1,344.87p Value: £67,243.50

Company: RS Group Name: David Sleath Volume: 6,222 Price: 803.5p Value: £49,993.77

Company: RS Group Name: David Sleath Volume: 5,226 Price: 803.6p Value: £41,996.14

Company: Virgin Money UK Name: Sara Weller Volume: 20,000 Price: 151.87p Value: £30,373.60

Company: Fidelity Special Values Name: Ominder Dhillon Volume: 4,000 Price: 277.9p Value: £11,115.96

Company: Lloyds Banking Group Name: Jasyjot Singh Volume: 20,326 Price: 47.14p Value: £9,581.68

Company: C&C Group Name: Vineet Bhalla Volume: 5,000 Price: 141.4p Value: £7,070.00

Company: Lloyds Banking Group Name: Janet Pope Volume: 2,278 Price: 47.4p Value: £1,079.66

Company: Lloyds Banking Group Name: Stephen Shelley Volume: 1,994 Price: 47.4p Value: £945.06

Company: Lloyds Banking Group Name: Kate Cheetham Volume: 1,799 Price: 47.4p Value: £852.64

Company: Lloyds Banking Group Name: Antonio Lorenzo Volume: 1,211 Price: 47.4p Value: £573.96

Company: Lloyds Banking Group Name: John Winter Volume: 853 Price: 47.14p Value: £402.10

Company: Lloyds Banking Group Name: Jasyjot Singh Volume: 97 Price: 47.4p Value: £45.97

Share this article

Related Sharecast Articles

Director dealings: Tracsis director snaps up shares
(Sharecast News) - Tracsis revealed on Wednesday that non-executive director Tracy Sheedy had acquired 950 ordinary shares in the AIM-listed transport software provider.
Director dealings: Admiral director raises stake
(Sharecast News) - Admiral Group revealed on Tuesday that non-executive director Justine Roberts had acquired 1,044 ordinary shares in the FTSE 100-listed insurer.
Director dealings: Creo Medical chairman raises stake
(Sharecast News) - Creo Medical revealed on Monday that chairman Kevin Crofton had acquired 1.17m ordinary shares in the London-listed medical device company.
Director dealings: Rentokil Initial director makes share purchase
(Sharecast News) - Rentokil Initial revealed on Friday that non-executive director Brian Baldwin had acquired 7.5m ordinary shares in the FTSE 100-listed pest control business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.